Biomedical Diagnostics to develop breast cancer test
This article was originally published in Clinica
Executive Summary
Two companies jointly funding and developing an early diagnostic test for breast cancer have formed a commercial company to take the idea further. Biotherapies of Ann Arbor, Michigan and BioLabs, based in New York, have launched Biomedical Diagnostics, with BioLabs providing initial funding of $1.5 million. The two companies have been co-operating since the beginning of the year.